The antibiotic resistance of Klebsiella pneumonia and Escherichia coli isolates and the spread of carbapenemases in a multidisciplinary hospital

The study of antibiotic resistance of Klebsiella pneumonia and Escherichia coli isolates and the distribution of carbapenemase genes was conducted in the multi-profile emergency hospital in the Republic of Sakha (Yakutia).

The structure of isolated microorganisms is dominated by pathogens of Enterobacterales genus: K. pneumonia was isolated in 29.9% (n=3314) and E. coli 20.8% (n=2306) of samples. The proportion of meropenem-resistant K. pneumonia strains was 47.5% of isolates, E. coli 13%. As a result of the study, totally 8 carbapenemase genes were isolated. The most common genes for K. pneumonia and E. coli isolates by detection frequency were OXA48 (24.9%), ctxM-1 (24.0%), SHV (21.8%), TEM (12.9%) and NDM (10.8%). In this case, combinations of 3 to 5 gene types were most often observed: 3 types were isolated in 86 (33.9%) strains, 4 types in 56 (22.0%) and 5 types in 54 (21.3%). The presence of 1 gene type was found in 33 (13.0%) strains, 2 types in 16 (6.3%), 6 types in 3 (1.2%) and 7 types in 6 (2.4%). Microbiological monitoring, control of local resistance to antibiotics in the hospital and the study of resistance mechanisms can increase the effectiveness of antimicrobial therapy, and also serve as an effective method of combating the spread of resistant strains of microorganisms.

1. Analysis of the structure of bacteremia and sensitivity to antibiotics of microorganisms isolated in intensive care units in an emergency hospital in the period from 2003 to 2021: a retrospective observational study / Bykov А.О., Suvorova M.P., Protsenko D.N. [et al.]// Annals of Critical Care. 2023.(2).55–65. https://doi:10.21320/1818-474X-2023-2-55-65.

2. Antimicrobial resistance of clinical isolates of Klebsiella pneumoniae and Escherichia coli in Russian hospitals: results of a multicenter epidemiological study/ Edelstein M.V., Shaidullina E.R., Ivanchik N.V. //Clinical microbiology and antimicrobial chemotherapy. 2024. Vol. 26(1). 67-78. doi: 10.36488/cmac.2024.1.67-78.

3. Antimicrobial resistance of nosocomial Enterobacterales isolates in Russia: results of multicenter epidemiological study «MARATHON 2015–2016»/ Sukhorukova M.V., Edelstein M.V., Ivanchik N.V.// Clinical microbiology and antimicrobial chemotherapy. 2019. Vol 21(2).143-155. doi: 10.36488/cmac.2019.2.147-159.

4. Kozlov R.S., Golub A.V. To stop the progress of antimicrobial resistance today means to give a chance of mankind surviving tomorrow. Clinical microbiology and antimicrobial chemotherapy. 2019. Vol. 21(4). 310-315. doi: 10.36488/cmac.2019.4.310-315.

5. Monitoring of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae in a multidisciplinary hospital. Abstracts of the XXV International MACMACH Congress on Antimicrobial Therapy and Clinical Microbiology. May 24-26. 2023 . Moscow. / Shamaeva S.Kh., Markova V.N., Alekseeva S.A. [et al.]// Clinical Microbiology and antimicrobial chemotherapy. 2023. V. 25, Appendix 1. 64-65.

6. Prevalence of carbapenemase-encoding genes carriage in patients admitted to multidisciplinary hospital in Moscow / Ni O.G., Shifman E.M., Yakovlev S.V. [et al.] // Clinical Microbiology and antimicrobial chemotherapy. 2024. V.26 (2). 124-140. DOI: 10.36488/cmac.2024.3.345-355.

7. Russian recommendations. Determination of the sensitivity of microorganisms to antimicrobial drugs. Version 2024-02. Year of approval (frequency of revision): 2024; MAKMAKH, SSMU: Smolensk: 192. https://www.antibiotic.ru/minzdrav/category/clinical-recommendations/

8. Etiological structure of infections in patients of the surgical intensive care unit in the post-covid era/ Belotserkovskiy B.Z.1,2, Kruglov A.N.2, Ni O.G. [et al.] // Clinical Microbiology and antimicrobial chemotherapy. 2024. V.26.№2. 124-140. https://doi:10.36488/cmac.2024.2.124-140.

9. Аntimicrobial-resistance. https://www.who.int/ru/news-room/fact-sheets/detail/antimicrobial-resistance.

10. AntiMicrobial Resistance Cloud – онлайн платформа. https://amrcloud.net/ru/

11. Jeong I.S., Song J.Y. Epidemiological Characteristics of Carbapenemase Producing Carbapenem-Resistant Enterobacteriaceae Colonization. Asian Nurs Res (Korean Soc Nurs Sci). 2022.16(3).134-139. DOI: 10.1016/j.anr.2022.05.002.

12. The ongoing antibiotic resistance and carbapenemase encoding genotypes surveillance. The first quarter report of the INVIFAR network for 2024/Colín-Castro CA, López-Jácome LE, Rodríguez-García MJ [et al]// PLoS One. 2025. 20(4). doi: 10.1371/journal.pone.0319441.

13. Resistant Organism Network Investigators. Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study/Van Duin D., Arias C.A., Komarow L. [et al] // Lancet Infect Dis. 2020. 20(6).731-741. doi: 10.1016/S1473-3099(19)30755-8.

14. Zaragoza R., Vidal-Cortés P., Aguilar G. Update of the treatment of nosocomial pneumonia in the ICU. Crit Care. 2020; 24(1): 383. https://doi:10.1186/s13054-020-03091-2.